Coronavirus vaccine: SII to give 2 crore Covishield doses worth Rs 410 crore to Central govt free of cost Ruchika Sharma29 Dec 2022 11:15 AM ISTAmid a spike in COVID-19 cases in some countries, including China and South Korea, the government has sounded an alert and asked states and Union...
Centre nod to Bharat Biotech nasal COVID vaccine iNCOVACC, to be availabile in private hospitals Ruchika Sharma23 Dec 2022 3:31 PM ISTiNCOVACC is a recombinant replication-deficient adenovirus vectored vaccine with a pre-fusion stabilized SARS-CoV-2 spike protein.
COVID vaccine: SII seeks DCGI nod for market authorisation of Covovax as booster dose Ruchika Sharma23 Dec 2022 2:30 PM ISTNew Delhi: The Serum Institute of India (SII) has sought the drug regulator's approval for market authorisation of its COVID-19 vaccine Covovax as a...
DCGI gives nod to Bharat Biotech Intranasal 'Five Arms' COVID booster dose for restricted use Ruchika Sharma26 Nov 2022 11:30 AM ISTThe nasal vaccine can be taken after six months of the second dose. As this is non-invasive and needle-free, it becomes easy to administer.
Patient demands Rs 10 crore compensation for alleged paralysis after Covishield administration: Kerala HC issues notice to SII Ruchika Sharma19 Nov 2022 4:00 PM ISTThe petitioner submitted that her husband suffered a high fever on the same day that he received the vaccine and thereafter, his condition...
DCGI panel to hold discussion on intranasal "Five Arms" booster dose iNCOVACC on Nov 15: Sources Ruchika Sharma14 Nov 2022 1:30 PM ISTIt has now announced that iNCOVACC (BBV154) has received approval under Restricted Use in Emergency Situation for ages 18 and above.
Serum Institute stopped Covishield production in Dec 2021, says Poonawalla; claims there are no takers for booster shots as people are fed up Ruchika Sharma21 Oct 2022 12:30 PM ISTPune: Chief Executive Officer of Serum Institute of India (SII), Adar Poonawalla, on Thursday said the vaccine manufacturer stopped the production of...
Biological E Corbevax offers better immunity as heterologous booster shot Ruchika Sharma14 Oct 2022 12:30 PM ISTCORBEVAX can be administered as a booster six months after two doses of COVAXIN or COVISHIELD for all adults.
AstraZeneca beats US shareholder lawsuit over COVID vaccine disclosures Ruchika Sharma13 Sept 2022 4:00 PM ISTUS District Judge Paul Oetken said AstraZeneca and its executives had no "generalized duty" to disclose "negative facts" about the trials.
COVID vaccine: Biological E delivers 10 crore Corbevax doses to Centre Ruchika Sharma13 Aug 2022 4:00 PM ISTThe price of Corbevax for private COVID-19 vaccination centres is Rs. 250, inclusive of GST.
Govt panel recommends Biological E Corbevax as booster for adults vaccinated with Covaxin, Covishield Rahul Verma3 Aug 2022 4:25 PM ISTA government panel on Covid immunisation has recommended allowing Biological E's Corbevax as a precaution dose for adults fully vaccinated with either...
Govt panel recommends allowing Biological E Corbevax as booster for Covishield, Covaxin recipients Ruchika Sharma3 Aug 2022 2:30 PM ISTIndia's first indigenously developed RBD protein subunit vaccine Corbevax is currently being used to inoculate children in the age group of 12 to 14...
